Los Angeles Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-123,714
| Closed | -$1.29M | – | 1221 |
|
|
2023
Q4 | $1.29M | Sell |
123,714
-170,449
| -58% | -$1.78M | ﹤0.01% | 593 |
|
|
2023
Q3 | $3M | Buy |
+294,163
| New | +$3M | 0.01% | 378 |
|
|
2023
Q1 | – | Sell |
-41,929
| Closed | -$382K | – | 1295 |
|
|
2022
Q4 | $382K | Sell |
41,929
-34,955
| -45% | -$319K | ﹤0.01% | 964 |
|
|
2022
Q3 | $620K | Buy |
76,884
+3,943
| +5% | +$31.8K | ﹤0.01% | 856 |
|
|
2022
Q2 | $549K | Buy |
+72,941
| New | +$549K | ﹤0.01% | 935 |
|
|
2020
Q3 | – | Sell |
-46,769
| Closed | -$577K | – | 1524 |
|
|
2020
Q2 | $577K | Sell |
46,769
-1,083
| -2% | -$13.4K | ﹤0.01% | 1056 |
|
|
2020
Q1 | $430K | Sell |
47,852
-80,079
| -63% | -$720K | ﹤0.01% | 953 |
|
|
2019
Q4 | $1.25M | Sell |
127,931
-108,269
| -46% | -$1.06M | 0.01% | 769 |
|
|
2019
Q3 | $1.63M | Sell |
236,200
-250,400
| -51% | -$1.72M | 0.01% | 681 |
|
|
2019
Q2 | $4.49M | Buy |
486,600
+51,300
| +12% | +$473K | 0.02% | 457 |
|
|
2019
Q1 | $6.83M | Sell |
435,300
-215,900
| -33% | -$3.39M | 0.04% | 376 |
|
|
2018
Q4 | $10M | Buy |
651,200
+598,900
| +1,145% | +$9.24M | 0.06% | 264 |
|
|
2018
Q3 | $1.13M | Buy |
52,300
+11,400
| +28% | +$246K | 0.01% | 831 |
|
|
2018
Q2 | $995K | Buy |
+40,900
| New | +$995K | 0.01% | 906 |
|
|
2018
Q1 | – | Sell |
-126,981
| Closed | -$2.41M | – | 1414 |
|
|
2017
Q4 | $2.41M | Sell |
126,981
-179,735
| -59% | -$3.41M | 0.01% | 616 |
|
|
2017
Q3 | $5.4M | Buy |
306,716
+109,239
| +55% | +$1.92M | 0.03% | 418 |
|
|
2017
Q2 | $6.56M | Buy |
+197,477
| New | +$6.56M | 0.04% | 393 |
|